Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the detailed record of transactions filed by Beraud Jill, Director. Insider active across 2 companies, notably Revance Therapeutics, Inc.. Cumulatively, 33 reports have been published. History available since 5 May 2021. The latest transaction was disclosed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Beraud Jill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
222 shares0Class A Common StockSEC:0001209191-22-031970:0
25 of 33 declarations
About Beraud Jill
Beraud Jill is Administrateur at Levi Strauss & Co and Revance Therapeutics, Inc. She has 32 filings in total, and across the 32 sampled filings, the period runs from 2021-05-07 to 2026-04-24. The modal transaction nature is Attribution, and the buy and sell amounts are both EUR 0 in the sampled filings.